Ralph E. Parchment
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 38
- PARP inhibition in cancer therapy 17
- Cancer Cells and Metastasis 7
-
- Cancer therapeutics and mechanisms 21
- Cell death mechanisms and regulation 7
- Developmental Biology and Gene Regulation 6
- Co-authors
- James H. Doroshow (44 shared papers)Robert J. Kinders (35 shared papers)G. Barry Pierce (11 shared papers)Joseph E. Tomaszewski (29 shared papers)Andrea L. Lewellyn (3 shared papers)Shivaani Kummar (20 shared papers)Larry Rubinstein (16 shared papers)Jiuping Jay Ji (12 shared papers)
- Journals
- Clinical Cancer Research (19 papers)Cancer Chemotherapy and Pharmacology (12 papers)Investigational New Drugs (9 papers)Molecular Cancer Therapeutics (7 papers)PLoS ONE (5 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Ralph E. Parchment
128 papers receiving 5k citations
Ralph E. Parchment's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.5k
- Cancer Research 466
- Small Animals 230
- Statistics and Probability 306
- Molecular Biology 1.5k
Countries citing papers authored by Ralph E. Parchment
This map shows the geographic impact of Ralph E. Parchment's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph E. Parchment with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph E. Parchment more than expected).
Fields of papers citing papers by Ralph E. Parchment
This network shows the impact of papers produced by Ralph E. Parchment. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph E. Parchment. The network helps show where Ralph E. Parchment may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph E. Parchment, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 262 | |
| 2 | 2011 | 220 | |
| 3 | 2010 | 218 | |
| 4 | 2010 | 200 | |
| 5 | 2012 | 185 | |
| 6 | 1991 | 183 | |
| 7 | 2007 | 168 | |
| 8 | 2009 | 152 | |
| 9 | 2009 | 135 | |
| 10 | 2012 | 132 | |
| 11 | 1999 | 116 | |
| 12 | Atezolizumab for Advanced Alveolar Soft Part Sarcoma Hit paper breakdown → | 2023 | 105 |
| 13 | 2001 | 100 | |
| 14 | 2009 | 99 | |
| 15 | 2016 | 95 | |
| 16 | 1997 | 94 | |
| 17 | 1989 | 91 | |
| 18 | 1993 | 89 | |
| 19 | 2010 | 88 | |
| 20 | 2019 | 83 |
About Ralph E. Parchment
Ralph E. Parchment is a scholar working on Oncology, Molecular Biology, Statistics and Probability, Small Animals and Immunology, having authored 131 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (21 papers), PARP inhibition in cancer therapy (17 papers), Statistical Methods in Clinical Trials (13 papers), Animal testing and alternatives (10 papers), Immunotoxicology and immune responses (9 papers), Cancer Cells and Metastasis (7 papers), Cell death mechanisms and regulation (7 papers) and Developmental Biology and Gene Regulation (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (466 citations), Small Animals (230 citations), Statistics and Probability (306 citations) and Molecular Biology (1.5k citations). Ralph E. Parchment has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include James H. Doroshow, Robert J. Kinders, G. Barry Pierce, Joseph E. Tomaszewski, Andrea L. Lewellyn, Shivaani Kummar, Larry Rubinstein, Jiuping Jay Ji, Melinda G. Hollingshead and Yves G. Pommier. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Molecular Cancer Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.